StockWatch
·
Medical/Dental Instruments
Quarterly ResultMay 6, 2026, 06:13 AM

AtriCure Q1 Revenue $141.2M, +14.3%; Net Income $0.1M; EPS $0.00

AI Summary

AtriCure reported strong first quarter 2026 financial results, with worldwide revenue increasing 14.3% year-over-year to $141.2 million. The company achieved net income of $0.1 million and adjusted EBITDA of $17.1 million, with basic and diluted net income per share at breakeven. U.S. revenue growth accelerated to 14.9%, driven by key product sales. For the full year 2026, AtriCure projects revenue of $600 million to $610 million and adjusted EBITDA of $80 million to $82 million.

Key Highlights

  • Worldwide revenue for Q1 2026 was $141.2 million, an increase of 14.3% year-over-year.
  • Net income for Q1 2026 was $0.1 million, with basic and diluted EPS at $0.00.
  • Adjusted EBITDA for Q1 2026 increased 95% to $17.1 million.
  • U.S. revenue grew 14.9% to $116.2 million, driven by key product sales.
  • International revenue increased 11.5% to $25.0 million.
  • Gross margin improved to 77.4% in Q1 2026, up 246 basis points.
  • Full year 2026 revenue guidance is projected to be $600 million to $610 million.
  • Full year 2026 Adjusted EBITDA guidance is approximately $80 million to $82 million.